ContraFect Corp. (NASDAQ:CFRX) – William Blair issued their Q3 2016 earnings estimates for shares of ContraFect Corp. in a research report issued on Tuesday. William Blair analyst Y. Xu expects that the firm will earn ($0.18) per share for the quarter. William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for ContraFect Corp.’s Q4 2016 earnings at ($0.18) EPS, FY2016 earnings at ($0.98) EPS, FY2017 earnings at ($0.68) EPS and FY2018 earnings at ($0.75) EPS.
ContraFect Corp. (NASDAQ:CFRX) last released its quarterly earnings data on Tuesday, August 9th. The company reported ($0.35) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.27) by $0.08.
Other equities analysts have also recently issued reports about the company. Maxim Group cut ContraFect Corp. from a “buy” rating to a “hold” rating in a report on Friday, July 22nd. Piper Jaffray Cos. began coverage on ContraFect Corp. in a research report on Thursday, July 28th. They set an “overweight” rating for the company.
ContraFect Corp. (NASDAQ:CFRX) opened at 2.48 on Friday. The firm’s 50-day moving average price is $2.39 and its 200-day moving average price is $2.87. ContraFect Corp. has a 1-year low of $2.10 and a 1-year high of $5.35. The firm’s market cap is $103.02 million.
A number of institutional investors have recently added to or reduced their stakes in the company. BlackRock Fund Advisors increased its position in ContraFect Corp. by 41.9% in the second quarter. BlackRock Fund Advisors now owns 57,923 shares of the company’s stock valued at $167,000 after buying an additional 17,092 shares during the last quarter. Sunbelt Securities Inc. acquired a new stake in shares of ContraFect Corp. during the second quarter worth approximately $578,000. Adage Capital Partners GP L.L.C. increased its stake in shares of ContraFect Corp. by 50.0% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,500,000 shares of the company’s stock worth $5,100,000 after buying an additional 500,000 shares in the last quarter. Finally, Cormorant Asset Management LLC increased its stake in shares of ContraFect Corp. by 256.0% in the first quarter. Cormorant Asset Management LLC now owns 834,406 shares of the company’s stock worth $2,837,000 after buying an additional 600,000 shares in the last quarter. 13.55% of the stock is owned by institutional investors.
In related news, CEO Steven C. Gilman purchased 20,000 shares of the company’s stock in a transaction on Wednesday, July 27th. The stock was bought at an average price of $2.48 per share, with a total value of $49,600.00. Following the completion of the transaction, the chief executive officer now owns 20,000 shares of the company’s stock, valued at approximately $49,600. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 15.00% of the company’s stock.
Receive News & Ratings for ContraFect Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corp. and related companies with MarketBeat.com's FREE daily email newsletter.